Cargando…
Management of lung disease in alpha-1 antitrypsin deficiency: what we do and what we do not know
Management of lung disease in patients with alpha-1 antitrypsin deficiency (AATD) includes both non-pharmacological and pharmacological approaches. Lifestyle changes with avoidance of environmental pollutants, including tobacco smoke, improving exercise levels and nutritional status, all encompassed...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367208/ https://www.ncbi.nlm.nih.gov/pubmed/34408831 http://dx.doi.org/10.1177/20406223211010172 |